pharmaphorum

APRIL 5, 2022

It’s no secret that digital technologies are playing a significant role when it comes to shaping the next era of healthcare. Necessity accelerated the adoption of new and sophisticated technologies and systems throughout the COVID-19 pandemic, but this seismic shift towards digital health has opened up a gap in education. To successfully navigate the potential of digital technologies in healthcare, attention must be focused on upskilling professionals in the field to equip them with the necessar

123

123

Outsourcing Pharma

APRIL 7, 2022

The US Department of Health and Human Serviceâs Office of Research Integrity has uncovered evidence that Toni Brand committed fraud in a number of reports.

80

80

Pharma Mirror

APRIL 8, 2022

Cambridge, UK, CellCentric, aclinical stage, private biotechnology company pioneering small molecule inhibition of p300/CBP to treat cancer, today announces the appointments of Kris Frese as Director of Cancer Biology, and Andrew Hughes, who joins the Board as a Non-Executive Director. Both have stellar experience and track records in oncology research and development.

52

52

Board Vitals - Pharmacist

APRIL 8, 2022

Funding is something that must be considered when determining your undergraduate and graduate academic goals for nursing school. Nursing school is expensive. Depending on the type of school and nursing program you enroll in, total tuition can range from $6,000 for an associate degree to $100,000 for an advanced degree. Luckily, many organizations offer funding options to nursing students from grants to student loans to scholarships.

Medical Schools 52

Medical Schools 52

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

pharmaphorum

APRIL 4, 2022

The National Institutes of Health (NIH) is funding a nationwide study in the US to support research on long-COVID, chronic COVID, or as it’s scientifically known, post-acute sequelae of SARS-CoV-2 (PASC) in children. An estimated 10% to 30% of adults who contract COVID-19 suffer from long COVID. Though speciality departments and independent institutions have opened to study chronic COVID in adults, little research has been done to evaluate the long-term effects of the virus on children.

Vaccines 109

Vaccines Hospitals Dosage Immunization 109

Outsourcing Pharma

APRIL 7, 2022

Experts from the Decentralized Trials and Research Alliance and Rafael Pharmaceuticals discuss progress and possibilities during Clinical Development Advances.

75

75

Board Vitals - Pharmacist

APRIL 7, 2022

If you’re like most nursing students, your clinical experiences will be either the best or worse (or potentially both) part of nursing school. There are many factors that influence the quality of your clinical experience. Most of which are out of your control, but despite that, you hold the keys to success during your nursing school clinicals. . Be a Learner First.

Patient Care 52

Patient Care Hospitals 52

pharmaphorum

APRIL 6, 2022

Ensuring that patients remain consistent with their therapies is one of the major challenges facing healthcare, so what if you could make treatment a game? That’s the potential behind game-based digital therapeutics and it’s drawing a lot of interest, finds Ben Hargreaves. The impact of video games on modern culture can be felt by even those that have little or no interest in them.

FDA 109

FDA 109

Outsourcing Pharma

APRIL 6, 2022

The excipients, equipment, and API companies have joined forces on Inhalation Together, an initiative aimed at advancing dry-powder inhalation solutions.

75

75

Pharma Mirror

APRIL 7, 2022

Let’s face it, dealing with a terminal illness diagnosis will never be an easy task and there’s not much you can do to mitigate the pain. However, there are a few steps that you can take to make the whole ordeal a bit more manageable for the person diagnosed and those around them. There are a few emotional chapters you’ll need to close as well as some practical matters that you should get out of the way if you are diagnosed with a terminal illness.

52

52

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharma Marketing Network

APRIL 4, 2022

The American Academy of Dermatology (AAD) held its annual conference last weekend, and it was my privilege to be in attendance. As COVID-19 had put the brakes on the show for the past two years, that same sentiment was shared by most of the attendees and exhibitors this year. Admittedly, attendance was down slightly from previous years, but that just meant shorter lines and extra opportunity to learn at each booth, and I have no doubt that it will exceed its former glory once COVID goes the way

52

52

pharmaphorum

APRIL 6, 2022

Boehringer Ingelheim says it is planning to invest a hefty €25 billion ($27 billion) in its pipeline over the next five years, as it reinvests healthy sales revenue from Eli Lilly-partnered SGLT2 inhibitor Jardiance. The German group has just reported a 28% increase in Jardiance (empagliflozin) sales to €3.9 billion in 2021, buoyed by new approval in heart failure, which was accompanied by a 25% gain for pulmonary fibrosis therapy Ofev (nintedanib) to €2.5 billion.

FDA 97

FDA 97

Outsourcing Pharma

APRIL 5, 2022

Leaders from some of the industryâs most notable companies are working together to streamline and automate IDMP workflow and come up with various standards.

73

73

Pharma Mirror

APRIL 6, 2022

London, ATMPS Ltd/Hataali – the leader in blockchain-based data sharing platforms for advanced therapies – announces it has been granted a patent from the United States Patent and Trademark Office (USPTO) for the use of blockchain technologies in personalised medicines. The company also has applications pending in both Europe and Asia as it looks to cement its technological advantage in the rapidly growing advanced therapy space globally.

52

52

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Med Ed 101

APRIL 6, 2022

In this COPD case study, we outline how to use the GOLD guidelines to guide medication therapy. Here’s the case! KE is a 71-year-old male who has a history of cigarette smoking for 50+ years, COPD, cardiovascular disease, hypertension, peripheral arterial disease, GERD, and osteoarthritis. His primary concern is his breathing and COPD. He presents […].

45

45

pharmaphorum

APRIL 8, 2022

Jazz Pharma has bolstered its pipeline of cancer drugs through a $1.3 billion licensing agreement with Werewolf Therapeutics that adds its first immuno-oncology candidate. The Dublin-based pharma is paying $15 million upfront for global rights to Werewolf’s WTX-613, a prodrug of the cytokine interferon alfa-2b, which is still back n preclinical development and due to start its first clinical trials next year.

Immunization 95

Immunization 95

Outsourcing Pharma

APRIL 4, 2022

Working with numerous partners, DiMe has introduced the 3Ps of Digital Endpoint Value to help inclusion of digital endpoints in drug reimbursement decisions.

52

52

Pharma Mirror

APRIL 6, 2022

GENT, BELGIUM, eTheRNA immunotherapies NV (“eTheRNA”), an mRNA technology discovery and development company with a full platform of integrated capabilities, is pleased to announce the relocation of its R&D group to a new and larger site in Gent, Belgium. The upgraded R&D facility is in the Zwijnaarde Science Park, where a cluster of biotech companies are located, and includes state-of-the-art laboratories together with allied services.

52

52

Med Ed 101

APRIL 3, 2022

Asthma and COPD are two disease states that we need to use inhalers. As a clinical pharmacist, I understand the importance of patient education. I’ve seen numerous mistakes with inhaler technique over the years in my practice as a clinical pharmacist. Here are some of those examples. Shaking The Inhaler I’ve seen this mistake go […].

45

45

pharmaphorum

APRIL 6, 2022

2021 was a big year in investment financing for US digital health companies, but there are signs that it may be a high watermark. In the first three months of this year there were 183 deals worth a total of $6 billion, giving an average size per deal of just under $33 million, according to venture fund Rock Health’s latest update on the sector.

93

93

Outsourcing Pharma

APRIL 5, 2022

Novartis has created a new organizational structure and operating model: which it says will make the company more agile and competitive.

52

52

Pharma Mirror

APRIL 6, 2022

New York, Kicking off the season for pharmaceutical professionals to come together digitally (09-27 May, 2022) as well as in-person (17-19 May, 2022). CPHI North America will be held as a SMART event, with three weeks of dedicated pharma learning and partnering. The benefit for the CPHI pharma community, which relies on a widening global supply chain, is that a SMART event format stimulates greater collaboration within the industry.

52

52

Pharma Times

APRIL 8, 2022

Alexion Pharma UK, AstraZeneca’s Rare Disease group, announces the recommendation of its pivotal neurofibromatosis treatment

47

47

pharmaphorum

APRIL 4, 2022

Gilead Sciences’ Kite Pharma has become the first drugmaker to get FDA approval to use a CAR-T therapy after just one earlier systemic therapy, moving the approach up the treatment pathway. The US regulator has cleared Kite’s CD19-targeted CAR-T Yescarta (axicabtagene ciloleucel) for people with large B-cell lymphoma (LBCL) refractory to one earlier therapy, or who have relapsed within 12 moths of first-line chemo-immunotherapy.

FDA 69

FDA Insurance 69

PharmD Live

APRIL 6, 2022

By PharmD Live Staff Writer. The Social Determinants of Health in the African-American community include all of the factors of the U.S. Government’s Healthy People 2030, a set of data-driven national goals for improving health for all Americans. Included is a focus on the Merit-based Incentive Pay System (MIPS). From poverty to food insecurity and violence, the history of racism can’t be ignored as a social determinant of health today.

Communication 52

Communication Hospitals 52

pharmaphorum

APRIL 6, 2022

Parliamentarians in the UK have warned that the government is not making the effort needed to reach its target of diagnosing three quarters of cancer cases at an early stage. If urgent action is not taken, England is at risk of remaining a laggard in cancer care among comparable countries like Australia and Canada, according to a new report from the Health and Social Care Committee.

64

64

pharmaphorum

APRIL 4, 2022

Two years after it was first proposed and a year after it officially launched, the pharma-backed AMR Action Fund has made its first investments in companies trying to tackle the pressing problem of antibiotic resistance. The Fund – set up as a public-private partnership by the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) – started life with $1 billion earmarked to support companies trying to develop antibiotics that can be used to replace those that have star

Hospitals 64

Hospitals 64

pharmaphorum

APRIL 8, 2022

People with psoriasis who used an app developed by digital health company Happify reported reduced anxiety and improvements in mental wellbeing in a real-world study involving more than two hundred subjects. It’s well recognised that people with psoriasis can develop depression or anxiety, particularly in moderate or severe cases where a sizeable part of the body can have skin lesions.

59

59

pharmaphorum

APRIL 8, 2022

pharmaphorum editor in chief Jonah Comstock takes on the Health Innovators series with a conversation with Amy Bucher, vice president of behavioural design at Lirio and author of “Engaged: Designing for Behavior Change”. Beyond patient engagement and patient activation is the idea of behaviour science and designing for effective behaviour change. Amy has spent her career engaging with these ideas and exploring their applications in the healthcare space.

59

59

pharmaphorum

APRIL 7, 2022

It is too early to consider widespread use of a second COVID-19 vaccine booster dose, according to the European Centre for Disease Prevention and Control (ECDC) and EMA’s COVID-19 task force (ETF). The official word from the EU authorities is that for now a fourth dose of Pfizer/BioNTech’s Comirnaty or Moderna’s SpikeVax – the preferred booster vaccines in Europe – should only be used in adults aged 80 years and over and people with compromised immunity.

Vaccines 59

Vaccines FDA Immunization Documentation 59

pharmaphorum

APRIL 4, 2022

April 4, 2022 – Zaid Siddiqui has been appointed as AXON’s new Global Healthcare Insights and Strategy Lead, an exciting asset for the healthcare communications agency. Zaid brings a decade of experience in the medical sector, with seven years of experience in medical insights and strategy. Zaid is particularly renowned for discovering compelling and strategic stories within the deluge of data.

Communication 59

Communication 59

pharmaphorum

APRIL 4, 2022

Multinational insurance company AXA has launched a new €440 million ($500 million) drive to provide private equity investments in healthcare companies that deepens its interest in the life sciences sector. Until now, AXA Investment Managers has been focused more on the delivery end of health care – health centres and private hospitals, for example – but the new strategy is directed at four key areas, including biopharma, vaccines, medical devices and diagnostics companies.

Insurance 59

Insurance Vaccines Hospitals 59

pharmaphorum

APRIL 8, 2022

With more than 6,000 different diseases comprising the rare disease (RD) landscape, connecting patients and practitioners with the expertise needed to achieve the correct diagnosis can be a significant barrier to treatment. . As the severity, progress and treatment potential of RD varies from patient to patient, each condition needs to be addressed differently using specialist expertise.

Hospitals 58

Hospitals 58

pharmaphorum

APRIL 7, 2022

BioXcel Therapeutics has claimed its first product approval, getting a green light from the FDA for Igalmi as a treatment for agitation in people with schizophrenia or bipolar disorder. Igalmi (dexmedetomidine) is the first drug to be approved for this use that is formulated as an tablet that dissolves under the tongue, and the first new treatment for agitation in patients with psychosis in almost a decade.

Labelling 52

Labelling FDA 52